Literature DB >> 20875075

Trypanosoma cruzi infection induces a massive extrafollicular and follicular splenic B-cell response which is a high source of non-parasite-specific antibodies.

Daniela A Bermejo1, María C Amezcua Vesely, Mahmood Khan, Eva V Acosta Rodríguez, Carolina L Montes, Maria C Merino, Kai Michael Toellner, Elodie Mohr, Dale Taylor, Adam F Cunningham, Adriana Gruppi.   

Abstract

Acute infection with Trypanosoma cruzi, the aetiological agent of Chagas' disease, results in parasitaemia and polyclonal lymphocyte activation. It has been reported that polyclonal B-cell activation is associated with hypergammaglobulinaemia and delayed parasite-specific antibody response. In the present study we analysed the development of a B-cell response within the different microenvironments of the spleen during acute T. cruzi infection. We observed massive germinal centre (GC) and extrafollicular (EF) responses at the peak of infection. However, the EF foci were evident since day 3 post-infection (p.i.), and, early in the infection, they mainly provided IgM. The EF foci response reached its peak at 11 days p.i. and extended from the red pulp into the periarteriolar lymphatic sheath. The GCs were detected from day 8 p.i. At the peak of parasitaemia, CD138(+) B220(+) plasma cells in EF foci, red pulp and T-cell zone expressed IgM and all the IgG isotypes. Instead of the substantial B-cell response, most of the antibodies produced by splenic cells did not target the parasite, and parasite-specific IgG isotypes could be detected in sera only after 18 days p.i. We also observed that the bone marrow of infected mice presented a strong reduction in CD138(+) B220(+) cells compared with that of normal mice. Hence, in acute infection with T. cruzi, the spleen appears to be the most important lymphoid organ that lodges plasma cells and the main producer of antibodies. The development of a B-cell response during T. cruzi infection shows features that are particular to T. cruzi and other protozoan infection but different to other infections or immunization with model antigens.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20875075      PMCID: PMC3015082          DOI: 10.1111/j.1365-2567.2010.03347.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  40 in total

1.  A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase.

Authors:  B Reina-San-Martín; W Degrave; C Rougeot; A Cosson; N Chamond; A Cordeiro-Da-Silva; M Arala-Chaves; A Coutinho; P Minoprio
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

Review 2.  Stromal niches, plasma cell differentiation and survival.

Authors:  Katrin Moser; Koji Tokoyoda; Andreas Radbruch; Ian MacLennan; Rudolf A Manz
Journal:  Curr Opin Immunol       Date:  2006-04-17       Impact factor: 7.486

3.  Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature.

Authors:  Elodie Mohr; Karine Serre; Rudolf A Manz; Adam F Cunningham; Mahmood Khan; Deborah L Hardie; Roger Bird; Ian C M MacLennan
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

4.  Peritoneum from Trypanosoma cruzi-infected mice is a homing site of Syndecan-1 neg plasma cells which mainly provide non-parasite-specific antibodies.

Authors:  Maria C Merino; Carolina L Montes; Eva V Acosta-Rodriguez; Daniela A Bermejo; Maria C Amezcua-Vesely; Adriana Gruppi
Journal:  Int Immunol       Date:  2010-03-05       Impact factor: 4.823

5.  DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection.

Authors:  P Sepulveda; M Hontebeyrie; P Liegeard; A Mascilli; K A Norris
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  Trypanosoma cruzi infection selectively renders parasite-specific IgG+ B lymphocytes susceptible to Fas/Fas ligand-mediated fratricide.

Authors:  Elina Zuñiga; Claudia C Motran; Carolina L Montes; Hideo Yagita; Adriana Gruppi
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

7.  B cell activation state-governed formation of germinal centers following viral infection.

Authors:  Katja Fink; Nataly Manjarrez-Orduño; Anita Schildknecht; Jacqueline Weber; Beatrice M Senn; Rolf M Zinkernagel; Hans Hengartner
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

8.  The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response.

Authors:  Cristina Gil-Cruz; Saeeda Bobat; Jennifer L Marshall; Robert A Kingsley; Ewan A Ross; Ian R Henderson; Denisse L Leyton; Ruth E Coughlan; Mahmood Khan; Karina T Jensen; Christopher D Buckley; Gordon Dougan; Ian C M MacLennan; Constantino López-Macías; Adam F Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-01       Impact factor: 11.205

9.  The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination.

Authors:  Peter J Hotez; Maria Elena Bottazzi; Carlos Franco-Paredes; Steven K Ault; Mirta Roses Periago
Journal:  PLoS Negl Trop Dis       Date:  2008-09-24

10.  Germinal center architecture disturbance during Plasmodium berghei ANKA infection in CBA mice.

Authors:  Leonardo J M Carvalho; Maria F Ferreira-da-Cruz; Claudio T Daniel-Ribeiro; Marcelo Pelajo-Machado; Henrique L Lenzi
Journal:  Malar J       Date:  2007-05-16       Impact factor: 2.979

View more
  33 in total

Review 1.  Pathogen manipulation of B cells: the best defence is a good offence.

Authors:  Katharina Nothelfer; Philippe J Sansonetti; Armelle Phalipon
Journal:  Nat Rev Microbiol       Date:  2015-02-09       Impact factor: 60.633

2.  Antigen-driven induction of polyreactive IgM during intracellular bacterial infection.

Authors:  Derek D Jones; Gregory A DeIulio; Gary M Winslow
Journal:  J Immunol       Date:  2012-06-22       Impact factor: 5.422

3.  Hydroxymethylnitrofurazone treatment in indeterminate form of chronic Chagas disease: Reduced intensity of tissue parasitism and inflammation-A histopathological study.

Authors:  Cauê B Scarim; Cleverton R de Andrade; João A da Rosa; Jean L Dos Santos; Chung M Chin
Journal:  Int J Exp Pathol       Date:  2018-10-15       Impact factor: 1.925

4.  Immunopathologic characterization of naturally acquired Trypanosoma cruzi infection and cardiac sequalae in cynomolgus macaques (Macaca fascicularis).

Authors:  Harshan Pisharath; Chih-Ling Zao; John Kreeger; Susan Portugal; Thomas Kawabe; Tarea Burton; Lisa Tomaeck; Ahmed Shoieb; Brandy Morenko Campbell; Judy Franco
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

Review 5.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

6.  Pathology of spontaneous and immunotherapy-induced tumor regression in a murine model of melanoma.

Authors:  Kim R M Blenman; Jake Wang; Shawn Cowper; Marcus Bosenberg
Journal:  Pigment Cell Melanoma Res       Date:  2019-02-27       Impact factor: 4.693

7.  Induction of Effective Immunity against Trypanosoma cruzi.

Authors:  Tere Williams; Ignacio Guerrero-Ros; Yanfen Ma; Fabiane Matos Dos Santos; Philipp E Scherer; Ruth Gordillo; Aline Horta; Fernando Macian; Louis M Weiss; Huan Huang
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

Review 8.  Investigating disease severity in an animal model of concurrent babesiosis and Lyme disease.

Authors:  Purnima Bhanot; Nikhat Parveen
Journal:  Int J Parasitol       Date:  2018-10-24       Impact factor: 3.981

Review 9.  Humoral immune responses to infection: common mechanisms and unique strategies to combat pathogen immune evasion tactics.

Authors:  Ismail Sebina; Marion Pepper
Journal:  Curr Opin Immunol       Date:  2018-02-23       Impact factor: 7.486

10.  Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells.

Authors:  Daniela A Bermejo; Shaun W Jackson; Melisa Gorosito-Serran; Eva V Acosta-Rodriguez; Maria C Amezcua-Vesely; Blythe D Sather; Akhilesh K Singh; Socheath Khim; Juan Mucci; Denny Liggitt; Oscar Campetella; Mohamed Oukka; Adriana Gruppi; David J Rawlings
Journal:  Nat Immunol       Date:  2013-04-07       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.